| 저자 |
Jisu Kim, Haesu Jeon, Myungyeon Kim, Arzu Velioğlu, Ye Na Kim, Ho Sik Shin, Yeonsoon Jung, Hark Rim, Anil Chandraker |
| 초록 |
In recent years, clinicians have been looking for objective scoring systems for providing accurate information on post-transplant outcomes. We tested the applicability of the Hennepin scoring system, which was recently validated in transplant recipients at the listing time in a different transplant center in the United States A total of 274 deceased kidney transplantation recipients (mean age 51.3∓14.9 years, F/M:113/161) transplanted between 2006-2015 were included in this study. In order to use the Hennepin score, age, functional status, cardiovascular co-morbidities, dialysis and diabetes status, were determined at the time of listing. A serious adverse outcome was defined as the presence of any of these events: mortality, graft loss, MI or stroke, ICU stay greater than 2 weeks, readmission requiring ICU admission, or care at a long-term care facility greater than 2 months (within the first year post transplant). Patients were stratified into 4 risk groups based on score (Table 1). Fifteen deaths and 19 graft losses were observed in the first year following transplantation. A total of 49 events occured in 43 patients. The incidence of severe adverse events 1 year post-transplant was 17.8 %. While only 8% of patients were stratified into the high risk group they accounted for 28% of the severe adverse outcomes, a patient in this group having a > 50% chance of a severe adverse outcome (Figure 1). The Hennepin transplant risk score showed moderately good discrimination for severe adverse events (c- statistics:0.648). These results provide external validation of the Hennepin score as a moderately good tool for discriminating short-term post-transplant morbidity for kidney transplantation recipients. The major advantage of this scoring is predicting the outcome at the listing time and providing a time for correction of pre-existing co-morbidities before transplantation. |